Singe Dose Study of PF- 06946860 in Healthy Adult Japanese Participants
Completed · Phase 1 · Has a placebo group
Conditions studied: Healthy
In brief
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of PF-06946860 in healthy adult Japanese participants following single dose administration.
Key facts
- Study ID
- NCT03974776
- Run by
- Pfizer
- People needed
- 8
- Starts
- 2019-07-08
- Expected to finish
- 2020-01-10
- Last updated by the study team
- 2020-01-29
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Anaheim Clinical Trials LLC-Clinical Research — Anaheim, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.